3-methoxytyramine has been researched along with Amino Acid Metabolism Disorders, Inborn in 1 studies
3-methoxytyramine: RN given refers to parent cpd
3-methoxytyramine : A monomethoxybenzene that is dopamine in which the hydroxy group at position 3 is replaced by a methoxy group. It is a metabolite of the neurotransmitter dopamine and considered a potential biomarker of pheochromocytomas and paragangliomas.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Pappan, KL | 1 |
| Kennedy, AD | 1 |
| Magoulas, PL | 1 |
| Hanchard, NA | 1 |
| Sun, Q | 1 |
| Elsea, SH | 1 |
1 other study available for 3-methoxytyramine and Amino Acid Metabolism Disorders, Inborn
| Article | Year |
|---|---|
Clinical Metabolomics to Segregate Aromatic Amino Acid Decarboxylase Deficiency From Drug-Induced Metabolite Elevations.
Topics: Amino Acid Metabolism, Inborn Errors; Aromatic-L-Amino-Acid Decarboxylases; Carbidopa; Child; Child, | 2017 |